Mutated KMT2A-PTD (KMT2A-Partial Tandem Duplication) (formerly MLL-PTD (Mixed Lineage Leukemia-PTD)) was demonstrated in 6% of adult AML patients, whereas in pediatric AML this incidence was lower at 2%. This evidence concerns the gene KMT2A and Bjornstad syndrome.